With 4 US FDA and EU approved API manufacturing facilities, one dedicated intermediate facility and a world class R&D lab housing 400 scientists with varied expertise, Biophore has emerged as one of the leading API companies globally.
We have consistently been in the Top 10 US DMF filers with the US FDA over the past 5 years and with most of our APIs, we are one of the fastest companies to bring them to the market enabling wider access for patients worldwide
Our aim is to place Biophore in the midst of most reliable knowledge based firms in the API sector in the immediate near-future through customer-focused approach.
Biophore strongly believes that education is the basic need for all and will empower the society towards building a great nation. We actively support in providing educational needs and infrastructure in various institutions and NGOs through participation, financial assistance and scholarship to the deserving students. Through this initiative, Biophore has supported the academic needs of 2000 students so far, which is considered as one of the biggest achievements of the organization today. We have also adopted 3 villages with an objective to improve the overall living conditions of the population.
Biophore is committed to ensure a safe and healthy work environment to its employees, contractors, vendors and customers. Located within the exclusive pharmaceutical manufacturing area, Biophore’s facilities remain compliant with all statutory laws and regulations. We conduct periodic safety audits on all our processes to mitigate any risks to the community. Our facilities are ISO14001:2015 certified.